Over more than eight years of monitoring, getting familiar with the EU CTR, conducting trial submissions activities, etc., ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data ...

At Mayo Clinic, the needs of the patient come first. Part of this commitment involves conducting medical research with the goal of helping patients live longer, healthier lives. Through clinical ...

Vistagen has reported positive outcomes from the exploratory Phase IIA trial of PH284 for the treatment of cancer cachexia.

Based on our experience and understanding of psychedelic therapy, here is our perspective on what the FDA guidance really means for psychedelic therapy clinical trials’ day-to-day work in trial ...

SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that an independent DSMB, which conducted a planned review of the 30-day safety data from a ...

For those who struggle with insurance or can’t afford cutting-edge health care, there’s an eye-opening opportunity coming to ...

A study finds that people who engage in just 30 minutes of exercise per week see modest improvements in body weight and body ...

Postdischarge contacts (PDCs) with patients after hospitalization are not associated with reductions in 30-day emergency department use or 30-day readmissions, ...

Corvus Pharmaceuticals (CRVS) announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial ...

Elderberry juice may improve metabolism and gut health, as a recent study found it lowers blood sugar and boosts fat burning ...